Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Post by Dandy07on May 05, 2020 2:01pm
180 Views
Post# 30988893

Interesting news..Alexion acquiring Portola

Interesting news..Alexion acquiring Portola

Anyone else who has other plays in the biotech sector.  Alexion is acquiring Portola Pharmaceuticals for 1.41 Bill.   

Of course with ico being partnered with Alexion, there's always a possibilty that if iCo has something worthwhile (ie.  Oral Amp B is what I am referring to) then there's always that potential.  Of course I am just speculating, as that is anyone's ultimate dream is a buyout.  Long way to go, but don't give up your shares just yet.  Good luck to everyone.

https://www.businesswire.com/news/home/20200505005333/en/Alexion-Acquire-Portola

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities